The Australian Collaboration for Coordinated Enhanced Sentinel Surveillance for STIs and BBVs (ACCESS) can help to evaluate the impact of public health interventions. The Laboratory Network, one of four ACCESS networks, collects testing and positivity data from laboratories across Australia. We explore chlamydia testing data to investigate if the National Sexually Transmissible Infections Prevention Program (NSTIPP) campaign, implemented nationally between May 2009 and November 2011, coincided with changes in population-level age-specific chlamydia testing rates in the target population (young people aged 15 to 29 years).
Methods: Testing data from laboratories participating in the ACCESS Laboratory Network (n=13) from five jurisdictions (NSW, VIC, SA, TAS and QLD) for 2008-2010 were extracted electronically using GRHANITE® software. Age-specific testing rates (tests per 100,000 population) were calculated using the ABS-projected population for each year in participating for individuals aged 15-75 years.
Results: The overall (15-75 years) testing rate (per 100,000 population) in 2008, 2009 and 2010 was 1046, 1322 and 1181, respectively. When stratified, the testing rate increased by 26% between 2008-2009; the largest increase in testing rate from 2008 to 2009 was observed in individuals aged 50-54 years (97% increase) rather than in the campaign target population (11% increase). The overall testing rate decreased by 12% for all age groups between 2009-2010, however the decrease was lower among individuals aged 15-29 years (7% decrease) .
Conclusion: Data showed that there was an increase in testing rates that coincided with the year the NSTIPP campaign was launched, however the largest increase was in older age groups rather than the target ages and changes in testing behavior were not sustained in 2010. These findings demonstrate the utility of the ACCESS Laboratory Network to measure population level changes in behavior following a national campaign such as the NSTIPP.
The case is of a 30 year-old HIV positive Zimbabwean woman (UK resident) who arrived in Australia in January 2011 on a one-year working visa. She was diagnosed with HIV in 2003 in the UK and commenced on Atripla® in 2005. She was first seen in Adelaide in May 2011, requesting a script for Atripla.®.
Background: Liquid based anal Papanicolaou smears, followed by High Resolution Anoscopy (HRA) guided biopsies are increasingly being advocated to identify areas of High Grade Anal Intraepithelial Neoplasia (HGAIN). We hypothesized that the ability to identify HGAIN would increase with experience of the anoscopist, and that comparison with contemporary Papanicolaou smears might yield insights into technical abilities.
Indigenous Australians experience a greater burden of sexually transmitted infections, however are less likely than the general population to access sexual health services. We examined the effectiveness of an Indigenous cultural appropriateness audit in assessing a sexual health clinic with low rates of Indigenous clients.
Despite the high proportion of young people annually accessing general practices, including Aboriginal Medical Services (AMS), testing for Chlamydia trachomatis remains relatively low in urban areas. A project officer was employed within the Institute of Urban Indigenous Health (IUIH) to serve a mentoring and facilitation role for the SE Queensland network of AMS and their sexual health workers, with a view to improving testing, management and follow-up of chlamydia and other STIs by community controlled medical services.
Monocytes are a heterogeneous cell population having specialised functions and differing phenotype. They are a link between innate immune system and adaptive immune system therefore, to identify if immune activation exists in HIV-1 individuals with controlled virema and recovered CD4 T cell counts, we assessed cell surface monocyte activation markers (MAM) within the monocyte subsets.
Involving consumers in healthcare decisions is important for high quality care. We previously tested a brief, consumer-led intervention consisting of three questions in a trial employing trained, standardized patients. The intervention enhanced discussion of evidence and increased patient involvement. We now report a research translation study which tested implementation with real patients at a reproductive and sexual health clinic.